Literature DB >> 26902518

Precision Medicine, Cardiovascular Disease and Hunting Elephants.

Michael J Joyner1.   

Abstract

Precision medicine postulates improved prediction, prevention, diagnosis and treatment of disease based on patient specific factors especially DNA sequence (i.e., gene) variants. Ideas related to precision medicine stem from the much anticipated "genetic revolution in medicine" arising seamlessly from the human genome project (HGP). In this essay I deconstruct the concept of precision medicine and raise questions about the validity of the paradigm in general and its application to cardiovascular disease. Thus far precision medicine has underperformed based on the vision promulgated by enthusiasts. While niche successes for precision medicine are likely, the promises of broad based transformation should be viewed with skepticism. Open discussion and debate related to precision medicine are urgently needed to avoid misapplication of resources, hype, iatrogenic interventions, and distraction from established approaches with ongoing utility. Failure to engage in such debate will lead to negative unintended consequences from a revolution that might never come.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical research; Genomics; Precision medicine

Mesh:

Substances:

Year:  2016        PMID: 26902518     DOI: 10.1016/j.pcad.2016.02.004

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  11 in total

Review 1.  Emerging Role of Precision Medicine in Cardiovascular Disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

2.  Pharmacogenetics: Chasing Perfection.

Authors:  Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-08       Impact factor: 6.875

Review 3.  Precision medicine in pediatric oncology: Lessons learned and next steps.

Authors:  Rajen J Mody; John R Prensner; Jessica Everett; D Williams Parsons; Arul M Chinnaiyan
Journal:  Pediatr Blood Cancer       Date:  2016-10-17       Impact factor: 3.167

Review 4.  Cardiovascular precision medicine: Bad news from the front?

Authors:  André P Lourenço; Adelino F Leite-Moreira
Journal:  Porto Biomed J       Date:  2017-07-01

Review 5.  Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms.

Authors:  Frank W Booth; Christian K Roberts; John P Thyfault; Gregory N Ruegsegger; Ryan G Toedebusch
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

6.  Exercise and Cardiovascular Disease Risk Factors in Children and Adolescents With Obesity: A Systematic Review With Meta-Analysis of Randomized Controlled Trials.

Authors:  George A Kelley; Kristi S Kelley; Russell R Pate
Journal:  Am J Lifestyle Med       Date:  2021-02-19

7.  The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ NaV1.5 Mutant of the Long QT Type 3 Syndrome.

Authors:  Julio Alvarez-Collazo; Alejandro López-Requena; Julio L Alvarez; Karel Talavera
Journal:  Biomolecules       Date:  2020-06-24

8.  Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.

Authors:  Ye Zhu; Kristi M Swanson; Ricardo L Rojas; Zhen Wang; Jennifer L St Sauver; Sue L Visscher; Larry J Prokop; Suzette J Bielinski; Liewei Wang; Richard Weinshilboum; Bijan J Borah
Journal:  Genet Med       Date:  2019-10-08       Impact factor: 8.822

9.  Evaluating the precision of EBF1 SNP x stress interaction association: sex, race, and age differences in a big harmonized data set of 28,026 participants.

Authors:  Abanish Singh; Michael A Babyak; Mario Sims; Solomon K Musani; Beverly H Brummett; Rong Jiang; William E Kraus; Svati H Shah; Ilene C Siegler; Elizabeth R Hauser; Redford B Williams
Journal:  Transl Psychiatry       Date:  2020-10-20       Impact factor: 6.222

10.  Why precision medicine is not the best route to a healthier world.

Authors:  Juan Pablo Rey-López; Thiago Herick de Sá; Leandro Fórnias Machado de Rezende
Journal:  Rev Saude Publica       Date:  2018-02-05       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.